193 related articles for article (PubMed ID: 14754977)
21. Comparative efficacy and safety of low-dose fluticasone propionate and montelukast in children with persistent asthma.
Ostrom NK; Decotiis BA; Lincourt WR; Edwards LD; Hanson KM; Carranza Rosenzweig JR; Crim C
J Pediatr; 2005 Aug; 147(2):213-20. PubMed ID: 16126052
[TBL] [Abstract][Full Text] [Related]
22. Preemptive use of high-dose fluticasone for virus-induced wheezing in young children.
Ducharme FM; Lemire C; Noya FJ; Davis GM; Alos N; Leblond H; Savdie C; Collet JP; Khomenko L; Rivard G; Platt RW
N Engl J Med; 2009 Jan; 360(4):339-53. PubMed ID: 19164187
[TBL] [Abstract][Full Text] [Related]
23. Adrenocortical activity with repeated administration of one-daily inhaled fluticasone propionate and budesonide in asthmatic adults.
Wilson AM; Clark DJ; Devlin MM; McFarlane LC; Lipworth BJ
Eur J Clin Pharmacol; 1998 Jan; 53(5):317-20. PubMed ID: 9516029
[TBL] [Abstract][Full Text] [Related]
24. No effect of fluticasone propionate on linear growth in preschool children with asthma.
Stefanovic IM; Verona E; Cicak B; Vrsalovic R
Pediatr Int; 2011 Oct; 53(5):672-676. PubMed ID: 21342354
[TBL] [Abstract][Full Text] [Related]
25. The effect of inhaled fluticasone propionate in the treatment of young asthmatic children: a dose comparison study.
Bisgaard H; Gillies J; Groenewald M; Maden C
Am J Respir Crit Care Med; 1999 Jul; 160(1):126-31. PubMed ID: 10390389
[TBL] [Abstract][Full Text] [Related]
26. Efficacy and safety of high-dose inhaled steroids in children with asthma: a comparison of fluticasone propionate with budesonide.
Ferguson AC; Spier S; Manjra A; Versteegh FG; Mark S; Zhang P
J Pediatr; 1999 Apr; 134(4):422-7. PubMed ID: 10190915
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of the effect of a large volume spacer on the systemic bioactivity of fluticasone propionate metered-dose inhaler.
Dempsey OJ; Wilson AM; Coutie WJ; Lipworth BJ
Chest; 1999 Oct; 116(4):935-40. PubMed ID: 10531156
[TBL] [Abstract][Full Text] [Related]
28. Diskus and diskhaler: efficacy and safety of fluticasone propionate via two dry powder inhalers in subjects with mild-to-moderate persistent asthma.
Galant SP; van Bavel J; Finn A; Gross G; Pleskow W; Brown A; Hamedani AG; Harding SM
Ann Allergy Asthma Immunol; 1999 Mar; 82(3):273-80. PubMed ID: 10094218
[TBL] [Abstract][Full Text] [Related]
29. Hypothalamic-pituitary-adrenal axis effects of mometasone furoate/formoterol fumarate vs fluticasone propionate/salmeterol administered through metered-dose inhaler.
Kosoglou T; Hubbell J; Cutler DL; Johnson-Levonas AO; Xu D; Kantesaria BS; Kim K; Miller SD
Chest; 2013 Dec; 144(6):1795-1802. PubMed ID: 24077095
[TBL] [Abstract][Full Text] [Related]
30. Salmeterol and fluticasone propionate (50/250 microg) administered via combination Diskus inhaler: as effective as when given via separate Diskus inhalers.
Chapman KR; Ringdal N; Backer V; Palmqvist M; Saarelainen S; Briggs M
Can Respir J; 1999; 6(1):45-51. PubMed ID: 10202220
[TBL] [Abstract][Full Text] [Related]
31. Initiation of maintenance therapy with salmeterol/fluticasone propionate combination therapy in moderate asthma: a comparison with fluticasone propionate.
Rojas RA; Paluga I; Goldfrad CH; Duggan MT; Barnes N
J Asthma; 2007; 44(6):437-41. PubMed ID: 17654129
[TBL] [Abstract][Full Text] [Related]
32. Airway and systemic effects of hydrofluoroalkane formulations of high-dose ciclesonide and fluticasone in moderate persistent asthma.
Lee DK; Fardon TC; Bates CE; Haggart K; McFarlane LC; Lipworth BJ
Chest; 2005 Mar; 127(3):851-60. PubMed ID: 15764767
[TBL] [Abstract][Full Text] [Related]
33. Efficacy and safety of ciclesonide once daily and fluticasone propionate twice daily in children with asthma.
Pedersen S; Engelstätter R; Weber HJ; Hirsch S; Barkai L; Emeryk A; Weber H; Vermeulen J
Pulm Pharmacol Ther; 2009 Jun; 22(3):214-20. PubMed ID: 19141327
[TBL] [Abstract][Full Text] [Related]
34. Adrenocortical activity with repeated twice daily dosing of fluticasone propionate and budesonide given via a large volume spacer to asthmatic school children.
Lipworth BJ; Clark DJ; McFarlane LC
Thorax; 1997 Aug; 52(8):686-9. PubMed ID: 9337826
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study.
Maspero J; Guerra F; Cuevas F; Gutierrez JP; Soto-Ramos M; Anderton S; Mechali D; Chan R; Pedersen S
Clin Ther; 2008 Aug; 30(8):1492-504. PubMed ID: 18803991
[TBL] [Abstract][Full Text] [Related]
36. Cost effectiveness of fluticasone propionate plus salmeterol versus fluticasone propionate plus montelukast in the treatment of persistent asthma.
O'Connor RD; Nelson H; Borker R; Emmett A; Jhingran P; Rickard K; Dorinsky P
Pharmacoeconomics; 2004; 22(12):815-25. PubMed ID: 15294013
[TBL] [Abstract][Full Text] [Related]
37. Effects of inhaled ciclesonide and fluticasone propionate on cortisol secretion and airway responsiveness to adenosine 5'monophosphate in asthmatic patients.
Derom E; Van De Velde V; Marissens S; Engelstätter R; Vincken W; Pauwels R
Pulm Pharmacol Ther; 2005; 18(5):328-36. PubMed ID: 15939311
[TBL] [Abstract][Full Text] [Related]
38. Secondary prevention of asthma by the use of Inhaled Fluticasone propionate in Wheezy INfants (IFWIN): double-blind, randomised, controlled study.
Murray CS; Woodcock A; Langley SJ; Morris J; Custovic A;
Lancet; 2006 Aug; 368(9537):754-62. PubMed ID: 16935686
[TBL] [Abstract][Full Text] [Related]
39. Efficacy and safety of dry powder fluticasone propionate in children with persistent asthma.
LaForce CF; Pearlman DS; Ruff ME; Silvers WS; Weinstein SW; Clements DS; Brown A; Duke S; Harding SM; House KW
Ann Allergy Asthma Immunol; 2000 Nov; 85(5):407-15. PubMed ID: 11101186
[TBL] [Abstract][Full Text] [Related]
40. Randomized, dose-ranging study of a fluticasone propionate multidose dry powder inhaler in adolescents and adults with uncontrolled asthma not previously treated with inhaled corticosteroids.
Kerwin EM; Gillespie M; Song S; Steinfeld J
J Asthma; 2017 Jan; 54(1):89-98. PubMed ID: 27285965
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
